SROAX
Price
$13.57
Change
+$0.07 (+0.52%)
Updated
Jul 25 closing price
Net Assets
4.64M
VFFSX
Price
$312.76
Change
+$1.26 (+0.40%)
Updated
Jul 25 closing price
Net Assets
1.49T
Interact to see
Advertisement

SROAX vs VFFSX

Header iconSROAX vs VFFSX Comparison
Open Charts SROAX vs VFFSXBanner chart's image
Calamos Antetokounmpo Sustainable Eqs A
Price$13.57
Change+$0.07 (+0.52%)
VolumeN/A
Net Assets4.64M
Vanguard 500 Index Institutional Select
Price$312.76
Change+$1.26 (+0.40%)
VolumeN/A
Net Assets1.49T
SROAX vs VFFSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
SROAX vs. VFFSX commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SROAX is a Buy and VFFSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VFFSX has more cash in the bank: 1.49T vs. SROAX (4.64M). VFFSX pays higher dividends than SROAX: VFFSX (1.23) vs SROAX (0.12). SROAX was incepted earlier than VFFSX: SROAX (2 years) vs VFFSX (9 years). SROAX (6.11) is less costly to investors than VFFSX (0.01). SROAX is a more actively managed with annual turnover of: 20.00 vs. VFFSX (2.00). SROAX has a lower initial minimum investment than VFFSX: SROAX (2500) vs VFFSX (5000000000). VFFSX annual gain was more profitable for investors over the last year : 17.94 vs. SROAX (12.38).
SROAXVFFSXSROAX / VFFSX
Total Expense Ratio1.350.0113,500%
Annual Report Gross Expense Ratio6.110.0161,100%
Fund Existence2 years9 years-
Gain YTD8.2148.27899%
Front Load5%N/A-
Min. Initial Investment250050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets4.64M1.49T0%
Annual Yield % from dividends0.121.2310%
Returns for 1 year12.3817.9469%
Returns for 3 yearsN/A62.50-
Returns for 5 yearsN/A98.17-
Returns for 10 years-8.43N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACTU7.260.27
+3.86%
Actuate Therapeutics Inc
NCL0.19N/A
+2.06%
Northann Corp
WAT302.954.48
+1.50%
Waters Corp
ACVA14.58-0.05
-0.34%
ACV Auctions Inc
STOK13.10-0.41
-3.03%
Stoke Therapeutics